A comprehensive comparison of AEGM with DCF, Dividend Discount Model, and other valuation approaches
The Abnormal Earnings Growth Model (AEGM), also known as the Residual Income Valuation Model or the Ohlson Model, represents one of the most theoretically robust approaches to equity valuation. Developed by James Ohlson in the 1990s, this framework links a firm's market value directly to its accounting numbers, specifically book value and future abnormal earnings. Unlike traditional valuation models that focus solely on cash flows or dividends, AEGM explicitly recognizes that value is created when a firm earns more than its cost of equity capital.
At its core, the model states that a company's equity value equals its book value plus the present value of expected future abnormal earnings. Abnormal earnings are defined as the difference between a firm's actual earnings and the earnings that equity holders would require as a minimum return on their investment (book value multiplied by the cost of equity). This seemingly simple adjustment has profound implications for how we think about value creation and measurement.
The DCF model is perhaps the most widely used valuation methodology in practice. It values a firm by discounting projected free cash flows at the weighted average cost of capital. While DCF is theoretically sound, it has several limitations that AEGM addresses:
The DDM values a stock as the present value of expected future dividends. While conceptually simple, DDM suffers from practical limitations:
| Feature | AEGM | DCF | DDM |
|---|---|---|---|
| Primary Input | Earnings & Book Value | Free Cash Flows | Dividends |
| Terminal Value Sensitivity | Low | High | Medium |
| Works for Non-Dividend Stocks | Yes | Yes | No |
| Financial Sector | Excellent | Poor | Fair |
| Negative Cash Flow Firms | Good | Poor | Fair |
| Value Driver Insight | High | Medium | Low |
| Complexity | Moderate | Moderate | Simple |
AEGM is closely related to the Residual Income (RI) model, sometimes used interchangeably. However, AEGM specifically focuses on the growth rate of abnormal earnings, providing a direct link to earnings growth forecasts that analysts commonly use. The RI model typically expresses value as book value plus discounted residual income, while AEGM frames it in terms of capitalized earnings plus the present value of abnormal earnings growth.
EVA, developed by Stern Stewart & Co., is a performance measurement framework derived from the same theoretical foundations as AEGM. While EVA focuses on measuring past and current economic profit, AEGM is forward-looking and designed specifically for valuation. Both frameworks emphasize that value is created only when returns exceed the cost of capital.
Trading and transaction multiples offer a market-based shortcut to valuation but suffer from severe limitations: they assume comparable firms are truly comparable, they ignore differences in growth, risk, and profitability, and they provide no intrinsic value anchor. AEGM provides a fundamental value based on firm-specific expectations, making it a superior tool for investment decisions.
In practice, abnormal earnings analysis is applied across several domains:
The growing adoption of AEGM reflects a broader shift toward accounting-based valuation models that bridge the gap between financial reporting and economic reality. As accounting standards evolve and data availability improves, the practical applications of abnormal earnings analysis will continue to expand.
For a complete guide with formulas, worked examples, and Excel templates, visit the Abnormal Earnings Growth Model page on our financial wiki.